TCM
ELV icon

Tandem Capital Management’s Elevance Health ELV Stock Holding History

Tandem Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Sell
6,562
-1,648
-20% -$542K 0.96% 39
2025
Q4 		$2.88M Buy
8,210
+110
+1% +$37.2K 1.31% 25
2025
Q3 		$2.62M Buy
8,100
+569
+8% +$177K 1.22% 26
2025
Q2 		$2.93M Sell
7,531
-17
-0.2% -$6.84K 1.48% 23
2025
Q1 		$3.28M Sell
7,548
-115
-2% -$46.2K 1.83% 18
2024
Q4 		$2.83M Sell
7,663
-18
-0.2% -$7.53K 1.51% 21
2024
Q3 		$3.99M Sell
7,681
-230
-3% -$123K 2.1% 13
2024
Q2 		$4.2M Sell
7,911
-135
-2% -$71.4K 2.3% 11
2024
Q1 		$4.17M Sell
8,046
-92
-1% -$45.8K 2.37% 9
2023
Q4 		$3.84M Sell
8,138
-376
-4% -$174K 2.38% 7
2023
Q3 		$3.71M Sell
8,514
-538
-6% -$244K 2.55% 8
2023
Q2 		$4.02M Buy
9,052
+3
+0% +$1.38K 2.62% 7
2023
Q1 		$4.16M Buy
9,049
+55
+0.6% +$26.2K 2.93% 7
2022
Q4 		$4.61M Sell
8,994
-79
-0.9% -$40.1K 3.64% 3
2022
Q3 		$4.64M Sell
9,073
-2
-0% -$957 3.91% 3
2022
Q2 		$4.38M Hold
9,075
– – 3.51% 4
2022
Q1 		$4.56M Hold
9,075
– – 3.16% 6
2021
Q4 		$4.21M Buy
9,075
+35
+0.4% +$14.7K 2.43% 13
2021
Q3 		$3.37M Buy
9,040
+58
+0.6% +$22K 2.12% 17
2021
Q2 		$3.43M Buy
8,982
+22
+0.2% +$8.41K 2.16% 17
2021
Q1 		$3.22M Buy
8,960
+46
+0.5% +$14.8K 2.22% 17
2020
Q4 		$2.86M Hold
8,914
– – 2.15% 18
2020
Q3 		$2.39M Buy
8,914
+50
+0.6% +$13.5K 2.11% 16
2020
Q2 		$2.33M Sell
8,864
-944
-10% -$252K 2.28% 14
2020
Q1 		$2.23M Buy
9,808
+160
+2% +$43.6K 2.51% 10
2019
Q4 		$2.91M Buy
+9,648
New +$2.65M 2.5% 10

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Tandem Capital Management's ELV Position: Q1 2026 in Review

Tandem Capital Management reduced its Elevance Health (ELV) stake by 20% in Q1 2026, selling an estimated $542K and leaving 6,562 shares worth $1.92M. The position accounts for 0.96% of the portfolio, ranked #39.

Tandem Capital Management first reported a position in ELV in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.64M in Q3 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Tandem Capital Management held 6,562 shares of Elevance Health worth $1.92M as of Q1 2026.
  • Tandem Capital Management sold 1,648 Elevance Health shares in Q1 2026, an estimated $542K.
  • Elevance Health made up 0.96% of Tandem Capital Management's portfolio in Q1 2026, its #39 holding.
  • Tandem Capital Management first reported a position in Elevance Health in Q4 2019 and has held it in 26 quarters since.
  • Tandem Capital Management's Elevance Health position peaked at $4.64M in Q3 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Tandem Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.